Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named ‘Best Places to Work’ by Boston Business Journal
Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual...
- MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual “Best Places to Work” list. Companies were selected based on survey responses provided by employees.
“This recognition reflects our commitment to building a culture where our talent can flourish and people can enjoy fulfilling careers – particularly in Boston, one of the most competitive biotechnology hubs in the world,” said Chris Ross, country speaker for the U.S.-based business sectors of Merck KGaA, Darmstadt, Germany. “We will continue to work hard to attract the best talent, ensure women have a path to leadership, and help ensure that the Boston area remains a great place to work and live.”
This is the 17th year that the Boston Business Journal has published its Best Places to Work list, and the first time that all three Massachusetts-based U.S. businesses of Merck KGaA, Darmstadt, Germany have won the award together. The company won in the extra-large company category and was one of only nine winning extra-large companies. Best Places to Work honors the area’s leading employers that go beyond the norm to foster a meaningful and enjoyable work environment and is based on internal employee survey results.
This year’s Best Places to Work companies were divided into five different categories: Extra small (20 to 49 employees), small (50 to 99 employees), medium (100 to 249 employees), large (250 to 999 employees) and extra-large (1,000 employees and over). The three businesses of Merck KGaA, Darmstadt, Germany have some 2,900 employees in Massachusetts.
The Boston Business Journal’s Best Places to Work surveys and the subsequent scoring of responses were provided in partnership with Quantum Workplace.
Follow Merck KGaA, Darmstadt, Germany on Twitter @emdgroup, on Facebook @emdgroup and on LinkedIn
All Merck KGaA, Darmstadt, Germany, news releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of €14.8 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA, Darmstadt, Germany Highlights Commitment to Improving Cancer Outcomes ...
Merck KGaA, Darmstadt, Germany, announced 43 abstracts covering modalities and mechanisms will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, Chicago, Ill., US.